Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stimuli‐Responsive Prodrug Chemistries for Cancer Therapy
Rupa Bargakshatriya, Sumit Kumar Pramanik
ChemBioChem (2023) Vol. 24, Iss. 18
Closed Access | Times Cited: 21

Showing 21 citing articles:

Research Progress of Disulfide Bond Based Tumor Microenvironment Targeted Drug Delivery System
Weiran Ma, Xiaoying Wang, Dongqi Zhang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 7547-7566
Open Access | Times Cited: 18
Leading prodrug strategies for targeted and specific release
Rupa Bargakshatriya, Sumit Kumar Pramanik
Future Medicinal Chemistry (2025), pp. 1-4
Closed Access | Times Cited: 1
Ultrasound-Controlled Prodrug Activation: Emerging Strategies in Polymer Mechanochemistry and Sonodynamic Therapy
Xuancheng Fu, Xiaoran Hu
ACS Applied Bio Materials (2024)
Open Access | Times Cited: 7
Stimulus‐Responsive Nano‐Prodrug Strategies for Cancer Therapy: A Focus on Camptothecin Delivery
Bingyang Chu, Hanzhi Deng, Ting Niu, et al.
Small Methods (2023) Vol. 8, Iss. 8
Closed Access | Times Cited: 14
pH/ROS co-triggered degradable polyprodrug as self-amplified drug self-delivery system for tumor-specific doxorubicin delivery
Xiaomei Zhao, Peng Liu
Colloids and Surfaces A Physicochemical and Engineering Aspects (2025), pp. 136094-136094
Closed Access
Programable Prodrug Nanomodulator Targets Tumor Redox Homeostasis Imbalance to Amplify Disulfidptosis and Immunogenic Pyroptosis for Breast Tumor Immunotherapy
Ayeskanta Mohanty, Adityanarayan Mohapatra, Woojin Yang, et al.
Advanced Healthcare Materials (2025)
Open Access
Carrier-free nano-prodrugs for enhanced cancer therapy: stimuli-responsive design and applications
Yoshitaka Koseki
Polymer Journal (2025)
Closed Access
Dual‐Stimuli‐Activatable Hybrid Prodrug for the Self‐Immolative Delivery of an Anticancer Agent and Hydrogen Sulfide with Turn‐On Fluorescence
Abu Sufian, Md. Badirujjaman, Pallavi Barman, et al.
Chemistry - A European Journal (2023) Vol. 29, Iss. 66
Closed Access | Times Cited: 10
Stimuli-Responsive Prodrugs with Self-Immolative Linker for Improved Cancer Therapy
Xu Wenting, Ang Jia, Zhixian Lei, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116928-116928
Closed Access | Times Cited: 3
Esterase-Responsive Fluorogenic Prodrugs of Aldose Reductase Inhibitor Epalrestat: An Innovative Strategy toward Enhanced Anticancer Activity
Roopjyoti Misra, Pallavi Barman, Krishna P. Bhabak
ACS Applied Bio Materials (2024) Vol. 7, Iss. 10, pp. 6542-6553
Closed Access | Times Cited: 2
Development of nano-immunotherapy for cancer treatment: achievements and scopes
Akhil Raj, Amal Babu, Vinoth Kumar Kothandan, et al.
Journal of Pharmaceutical Investigation (2023) Vol. 53, Iss. 6, pp. 827-844
Closed Access | Times Cited: 4
Anisamide-conjugated hairpin antisense oligonucleotides prodrug co-delivering doxorubicin exhibited enhanced anticancer efficacy
Zhe Zhang, Zuyi Chen, Shuangshuang Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116390-116390
Open Access | Times Cited: 1
Design and synthesis of dual functional NBD-fluorophore-incorporated naphthalene diimide derivatives as G-quadruplex ligands
Xinhang Zhang, Yashu Li, Yuchen Chen, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 111, pp. 129903-129903
Closed Access | Times Cited: 1
In vivo synthetic anticancer approach by resourcing mouse blood albumin as a biocompatible artificial metalloenzyme
K. Imai, Kyohei Muguruma, Akiko Nakamura, et al.
Angewandte Chemie International Edition (2024)
Closed Access
In vivo synthetic anticancer approach by resourcing mouse blood albumin as a biocompatible artificial metalloenzyme
K. Imai, Kyohei Muguruma, Akiko Nakamura, et al.
Angewandte Chemie (2024) Vol. 136, Iss. 43
Closed Access
Reactive oxygen species driven prodrug-based nanoscale carriers for transformative therapies
Shyam Vasvani, Arathy Vasukutty, Rizia Bardhan, et al.
Biomaterials Science (2024) Vol. 12, Iss. 17, pp. 4335-4353
Closed Access
An Acid‐Activatable Fluorescent Probe for Sulfur Dioxide in Traditional Chinese Medicines and Living cells
Guan Xi, Liwen Liu, Peitao Zhou, et al.
Chemistry - An Asian Journal (2024) Vol. 19, Iss. 20
Closed Access
pH-sensitive prodrugs
Emanuela Berrino, Sébastien Thibaudeau
Elsevier eBooks (2024), pp. 23-40
Closed Access
Advancing Cancer Immunotherapy through Engineering New PD-L1 Degraders: A Comprehensive Study from Small Molecules to PD-L1-Specific Peptide–Drug Conjugates
Zekun Zeng, Zhiwei Yang, Chenghao Li, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 21, pp. 19216-19233
Open Access
Molecular Matchmakers: Bioconjugation Techniques Enhance Prodrug Potency for Immunotherapy
Yinuo Chen, Nicholas E. Clay, Nathan Phan, et al.
Molecular Pharmaceutics (2024) Vol. 22, Iss. 1, pp. 58-80
Closed Access
Developing Dual-Responsive Quinolinium Prodrugs of 8-Hydroxyquinoline By Harnessing the Dual Chelating Sites
Xueyan Yao, Junjiao Wang, Jie Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117196-117196
Closed Access
Page 1

Scroll to top